PO-099: Combination of mTOR targeting with cetuximab, and chemotherapy: a preclinical study on head and neck cancer

Autor: Bozec, A., Ebran, N., Sudaka, A., Etinne-Grimaldi, M.C., Penaud-Llorca, F., Milano, G.
Zdroj: In Radiotherapy and Oncology February 2015 114 Supplement 1:49-50
Databáze: ScienceDirect